Bio-Rad Labs Inc. A buy UBS Group AG
Start price
08.05.24
/
50%
€248.20
Target price
08.05.25
€357.93
Performance (%)
-12.97%
End price
09.05.25
€216.00
Summary
This prediction ended on 09.05.25 with a price of €216.00. The price of Bio-Rad Labs Inc. A has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.97%. UBS_Group_AG has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | 3.881% | 3.881% | -22.009% |
| iShares Core DAX® | 0.683% | 0.785% | 38.055% |
| iShares Nasdaq 100 | -1.457% | 3.734% | 23.153% |
| iShares Nikkei 225® | 0.931% | 2.958% | 11.220% |
| iShares S&P 500 | -2.022% | 2.444% | 15.543% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $420.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€205.90
03.05.25
03.05.25
€274.38
03.05.26
03.05.26
9.18%
19:13
19:13
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-15.75%
17.02.25
17.02.25
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
8.65%
08.12.24
08.12.24